Stockscreener 앱 받기
4.31
0.35%
0.075
Pmgc Holdings Inc 주식(ELAB)의 최신 뉴스
ELAB stock plunges to 52-week low, touches $4.15 - Investing.com
PMGC Holdings executes modest stock repurchase By Investing.com - Investing.com South Africa
PMGC Holdings executes modest stock repurchase - Investing.com
Northstrive Biosciences Inc. Schedules Pre-IND Meeting with - GlobeNewswire
Northstrive Biosciences plans meeting with FDA for its new obesity reducing therapy -March 10, 2025 at 11:15 am EDT - Marketscreener.com
Northstrive Biosciences plans meeting with FDA for its new obesity reducing therapy - TradingView
Is PMGC Holdings (NASDAQ:ELAB) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
PMGC it has schedules a pre-IND meeting with FDA for EL-22 - TipRanks
ELABPMGC Holdings Latest Stock News & Market Updates - StockTitan
Is PMGC Holdings Inc (NASDAQ: ELAB) A Good Investment For New Investors Now? - Stocks Register
Nasdaq Down Over 400 Points; Kroger Posts Upbeat Earnings - Benzinga
ELAB’s price-to-free cash flow ratio: What it means for investors - US Post News
PMGC Holdings announces reverse stock split By Investing.com - Investing.com Australia
PMGC to Implement 1-for-7 Reverse Stock Split; Shares Fall -March 06, 2025 at 10:48 am EST - Marketscreener.com
Dow Tumbles 1%; US Initial Jobless Claims Decline - Benzinga
PMGC Holdings announces reverse stock split - Investing.com
PMGC announces 1-for-7 reverse stock split - TipRanks
PMGC Holdings Inc. Announces 1-for-7 Reverse Stock Split Effective March 10, 2025 - Nasdaq
PMGC Holdings Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance - The Manila Times
PMGC Holdings Announces Reverse Stock Split To Maintain Nasdaq Listing Compliance - Marketscreener.com
Can PMGC's Reverse Split Save Its Nasdaq Listing? Key Details Revealed - StockTitan
Elevai Labs stock plunges to 52-week low of $1.16 amid steep decline - Investing.com India
PMGC Holdings Ends License Agreement with INmune Bio By Investing.com - Investing.com South Africa
PMGC Holdings Ends License Agreement with INmune Bio - Investing.com
PMGC Holdings Inc. Expands Investment & M&A Efforts, - GlobeNewswire
PMGC Holdings Inc. Expands Investment & M&A Efforts, Actively Seeking Acquisitions and Investments Through Strategic Sponsorship of TCA Venture Group - The Manila Times
PMGC Holdings Inc. Announces Annual Sponsorship of TCA Venture Group's Orange County Network for 2025 - Nasdaq
How PMGC's New Angel Investor Partnership Could Accelerate Its Bioscience Acquisition Strategy - StockTitan
PMGC highlights ‘strong’ capital position - MSN
PMGC Holdings Highlights Strong Capital Position: No Debt, Fully Funded, and Warrants Priced Above Market - The Manila Times
PMGC Holdings Highlights Strong Capital Position: No Debt, Fully Funded, and Warrants Priced ... - The Bakersfield Californian
Is PMGC Holdings' Debt-Free Status Enough to Counter Its 335K Short Interest? - StockTitan
Elevai Labs stock hits 52-week low at $1.58 amid steep decline - Investing.com Canada
Elevai Labs stock hits 52-week low at $1.58 amid steep decline By Investing.com - Investing.com South Africa
Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings - GlobeNewswire
Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Announces Successful Submission of Pre-IND Meeting Request to FDA for EL-22, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with G - The Manila Times
Revolutionary Obesity Drug EL-22 Advances: Could Solve GLP-1's Biggest Problem - StockTitan
What Did We Find About Insider Trading At PMGC Holdings Inc (NASDAQ: ELAB)? - Stocks Register
Elevai Labs Inc. announced that it expects to receive $1 million in funding -July 30, 2024 - Marketscreener.com
Elevai Labs stock plunges to 52-week low of $1.61 amid steep decline - Investing.com Australia
Elevai Labs stock plunges to 52-week low of $1.61 amid steep decline By Investing.com - Investing.com South Africa
PMGC Holdings (NASDAQ:ELAB) Stock Quotes, Forecast and News Summary - Benzinga
The -96.65% Simple Moving Average of PMGC Holdings Inc’s (ELAB) Stock in the Past 200 Days - The News Heater
ELAB’s 2023 Market Dance: Down -19.21% – Time to Invest? - The InvestChronicle
Northstrive Biosciences, Inc., a Subsidiary of PMGC - GlobeNewswire
Evaluating ELAB’s financial ratios for a profitable investment - US Post News
1.14%
1.31%
자본화:
|
볼륨(24시간):